miRNA-Based Therapeutics for Heart Failure: Why Not?

Affiliations

¹ Université de Paris, PARCC, INSERM, Paris, France; CIC1418 and DMU CARTE, Assistance Publique - Hôpitaux de Paris, Hôpital Européen Georges-Pompidou, Paris, France. Electronic address: jean-sebastien.hulot@aphp.fr.
² Université de Paris, PARCC, INSERM, Paris, France.

Free article

Editorial

Jean-Sébastien Hulot et al. J Am Coll Cardiol. 2020.

Free article

. 2020 Apr 21;75(15):1801-1803.

doi: 10.1016/j.jacc.2020.03.003.

¹ Université de Paris, PARCC, INSERM, Paris, France; CIC1418 and DMU CARTE, Assistance Publique - Hôpitaux de Paris, Hôpital Européen Georges-Pompidou, Paris, France. Electronic address: jean-sebastien.hulot@aphp.fr.
² Université de Paris, PARCC, INSERM, Paris, France.

No abstract available

Keywords: animal; heart failure; microRNAs; models, pharmacology; preclinical.

Comment on

AntimiR-21 Prevents Myocardial Dysfunction in a Pig Model of Ischemia/Reperfusion Injury.
Hinkel R, Ramanujam D, Kaczmarek V, Howe A, Klett K, Beck C, Dueck A, Thum T, Laugwitz KL, Maegdefessel L, Weber C, Kupatt C, Engelhardt S. Hinkel R, et al. J Am Coll Cardiol. 2020 Apr 21;75(15):1788-1800. doi: 10.1016/j.jacc.2020.02.041. J Am Coll Cardiol. 2020. PMID: 32299591